SlideShare uma empresa Scribd logo
1 de 67
Japanese Encephalitis
&
Filariasis
Dr. Rahul Netragaonkar
Professor
Dept. Of Community Medicine
Zydus Medical College,
Dahod
INTRODUCTION
 Mosquito Borne Encephalitis Caused By Group B
Arbovirus
(Flavi Virus) And Transmitted By Culicine
Mosquitoes.
 Zoonotic Disease
(Metazoonoses)
 Rural Disaease
 Iceberg Disease
 Exhibits Cyclical Trend
History
• 1871 Japanese Encephalitis
Described In Japan.
• 1934 Japanese Encephalitis Virus
Was Isolated.
World Scenario
50000 Cases Of Je Occur Globally Each Year With
11000 De Aths And Nearly 9000 Disabled.
Sporadic Cases (Occasional Cases, Widely
Distributed In Time And Place): Are Observed In
China, Japan, Taiwan, Korea, Philippines, Indonesia,
Malaysia, Singapore, Myanmar, Bangladesh And
Eastern Areas Of Russia.
Regional, Seasonal Outbreaks : Occurs In
Thailand, Parts Of India And Sri Lanka.
INDIAN SCENARIO
• JE first isolated in 1955 at Vellore, Tamil Nadu.
• Subsequently, the outbreaks have occurred in 25 States
/ Union Territories of India.
• JE virus infection is widespread and is particularly
very high in Southern States of India viz., Andhra
Pradesh (AP) Tamil Nadu and some parts of
Karnataka.
NB: Indian authorities have reported 6171 cases nation-wide,
including 5700 cases and 1315 deaths in Uttar Pradesh alone.
YEAR CASES DEATHS
1998
1999
2000
2001
2002
2003
2004
2005
2120
3428
2593
2061
1765
2241
1695
6200
507
680
556
479
460
670
367
1315
INCIDENCE OF JE
Agent
Je Virus
Flavivirus
Ss-RNA
Enveloped
Icosahedral
Epidemological Aspects
NATURAL CYCLE OF JE VIRUS
Animal Reservoirs
• Pigs
Major Vertebrate Hosts
Considered As ‘Amplifiers’ Of Virus
• Cattles/Buffaloes
Not Natural Hosts Of Je Virus
Act As ’Mosquitc Attractants’
• Birds
Pond Herons,cattle Ergets,poultry,ducks
Nb:horses Are Only Animals Which Manifest Je Virus
Infection.
Host Factors
 Age:
Majority Of Cases Are Children Less Than 15 Years (85%) Or
Over 60 Years (10%).
 Sex:
Males Are More Affected Than Females.
 Population Mobility
Migration Of People From Endemic Areas To receptive areas.
 Occupation
Mostly A Rural Disease ,
Closely Related To Agricultural Practises.
ENVIRONMENTAL
FACTORS
 Season
Je Is A Seasonal Disease Prevalence Is From May To
October ( Related To Agricultural Practices).
 Rainfall
Increases The Opportunities For Breeding Of
Mosquitoes.
VECTOR OF JE
Culicine Mosquitoes.
(C.Tritaeniorhynchus,c.Vishnui,
C.Gelidus)
Some Anophelines.
C.Tritaeniorhynchus Has Been
Implicated As Important Vector
In South India.
HABITS
Breeding Habits
Breed In Rice Fields,
Shallow Ditches
And Pools.
Choice Of Host
Zoophilic,feeding Primarily On Animal Hosts.
Time Of Biting
Usually At Nights.
MODES OF TRANSMISSION
 Disease Is Transmitted To Man By Bite Of Infected
Mosquitoes.
 No Man To Man Transmission
 Man Is Incidental “Dead End” Host.
Incubation Period
Varies From 5-15 Days
PATHOGENESIS OF JE
LYMPH NODE
PATHOGENESIS
• Neurotransmitter receptors are involved in binding of JE
virus to cells in CNS.
• Sensitized T cells stimulate inflammatory
Response by activating macrophages, lymphocytes
Perivascular space and parenchyma to form glial nodules
CD4 T cells - CFS, parenchyma
B cells - perivascular space
CLINICAL FEATURES
• Divided into three stages:
1. Prodromal stage
2. Encephalitic stage
3. Late stage
CLINICAL FEATURES
• Incubation period-5 to 16 days
• Disease:asymptomatic infection=1:250 to 1:1000
• Represents tip of iceberg
• Disease depends on –severity of infection
susceptibility of host
location of agent
• It is characterized by CNS involvement
• Japanese encephalitis is also called BRAIN FEVER
SYMPTOMS AND SIGNS
• PRODROMAL PHASE:-
High grade fever,
headache
malaise
Duration :6 days
• ENCEPHALITIC STAGE:-
High fever, severe head ache, nuchal rigidity, focal
CNS signs, seizures, altered sensorium, abnormal
doll’s eye moments, absent corneal reflex, pupillary
reflex, deviation of angle of mouth, loss of
consciousness etc.
• Symptoms and signs of raised ICT-headache, vomiting,
hemiplegia,bradycardia,irregular breathing.
• Signs and symptoms of meningeal irration-kernigs sign
DURING OUTBREAK
HOSPITILISATION
• LATE STAGE:- Begins when active inflammation is
at end i.e.temp. and ESR touch normal
Mental impairment
Increased deep tendon reflexes
Paresis of UMN lesion
- LMN lesion type
- Speech impairment
• COMPLICATIONS:-
Death 35 - 50% - short prodromal stage
- deep coma
- hypertonia
- tachypnea
NB:If patient survives, complications are as that of
late stage.
• JE is the disease in children with early mortality.
DIAGNOSIS
• Clinical signs and symptoms
• LAB DIAGNOSIS:-
CSF lymphocytic pleocytosis
Normal glucose level
• SEROLOGICAL TESTS:-
Detection of IgM antibodies –first week
• NEW SEROLOGICAL TEST:-
ELISA shows sensitivity of 88% -with sera
81% -with CSF
Principles of Control :
• No specific treatment per se.
• Vector control is the main mode of prevention of an
individual and community as a whole.
• Control of amplifier hosts.
• Vaccination.
Management of J E
Only symptomatic treatment
• Maintenance of airway
• Fluid and electrolyte balance
• Control of convulsions,
raised Intra Cranial Pressure,
temperature
FILARIASIS
• INTRODUCTION
Worldwide prevalent, arthropod borne,
causing
permanent, long term disability &
disfigurement &
associated with social & economic
stigma.
It causes-Isolation
-Psychological stress
-Family discord
-Impair employment
-Impair mobility & domestic
activities
FILARIASIS
FILARIASIS
LYMPHATIC
Wuchereria
bancrofti
Brugia
malayi
Brugia timori
NON-
LYMPHATIC
Sub-
cutaneous
Onchocerca
volvulus
Loa loa
Mansonella
streptocerca
Serous
Mansonella
ozardi
Mansonella
perstans
Lymphatic filariasis
• Caused by W.Bancrofti
B.Malayi
B.Timori
History:
600 BC-SUSHRUTA described ELEPHENTANOID LEG.
1709 ad-the term malabar leg was applied by clarke.
1866 ad-Wucherer demonstrated mf in chylous urine.
1876 ad-bancroft described female adult worm.
1878 ad-manson identified culex as the vector &
Described periodicity.
This was the first discovery of insect transmission of a
Human disease.
PROBLEM STATEMENT
• Widely distributed in tropics & sub-tropics-ASIA,
AFRICA, WESTERN PACIFIC, SOUTH
AMERICA.
• Most seriously affected areas are INDIA, SOUTH
EAST ASIA, CHINA, EAST COAST of AFRICA &
NEW GUINEA.
• Affecting 120 million people in 83 countries.
• 40% of the affected people are in INDIA, 33% in
AFRICA.
LOA LOA (LOAIASIS)
• Confined to Africa.
• Vector Chrysops flies. They live in the rainy forest.
• Monkeys are the reservoir hosts.
ONCHOCERCA VOLVULUS (RIVER
BLINDNESS)
 Distributed in Africa & South America.
 Endemic in West Africa, Equatorial & East Africa &
Sudan.
 Vector - black fly = Simulum damnosum.
• W.bancrofti widely distributed throughout the tropics &
sub tropics which account for nearly 90% of the
lymphatic filariasis.
• Brugia malayi has only been recognized in ASIA &
localized to INDONESIA, MALAYSIA, PHILIPPINES,
THAILAND, VIETNAM, CHINA, SOUTH KOREA,
INDIA.
• Brugia timori is prevalent in islands of TIMOR &
FLORES. First described in 1964 from the island of
TIMOR of INDONESIA.
LYMPHATIC FILARIASIS
• IN INDIA
Only W.bancrofti & B.malayi are seen.
Endemic along coastal states – increasing
every year. Heavily infected areas are
found in U.P, Bihar, Jharkhand, A.P.,
Orissa, T.N., Kerala & Gujarat.
B.malayi – KERALA - largest endemic
area. ASSAM, ORISSA, M.P., W.B
-epidemic pockets.
• SYMPTOM PREVALENCE -
27 million - GENITALFILARIASIS
16 million - ELEPHANTIASIS of LEG
EPIDEMIOLOGY
AGENTS
W.BANCROFTI
B.MALAYI
B.TIMORI
Definite host is MAN.
Intermediate host is
MOSQUITO.
Adult worms live in LYMPHATIC
SYSTEM remain coiled together.
Male 2.5-4cm. &
Female 8-10cm.
Mf are seen in
blood, lung (capillaries), kidney
(glomerular tufts).
HUMANS - is a person with circulating Mf in
peripheral blood.
ANIMALS - no animal reservoir for Wb & Bt.Bm -
dogs, cats, monkeys, wild carnivores & rodents.
Reservoir
MAN is a natural host.
Age: all ages are susceptible. infectious rate rises with
age up to 20-30yrs.
Sex :higher in men.
Migration: causes extension of filariasis into areas
previously non endemic.
Immunity: resistance to infection after many years of
exposure.
HOST FACTORS
• A) Climate: is an imp. Factor in the epidemiology
of filariasis.it influences
1)Mosquito-longevity & breeding
2)determines the development of parasite in
the vector
Max. prevalence observed at temp.22-38°C
humidity-70%
B) Town planning: rapid urbanization in INDIA
causing inadequate sewage disposal –
aggravating the problem.
C) Drainage: mosq. breed profusely in polluted
water.
ENVIRONMENTAL FACTORS
1)Major leading cause of disability in the world.
2)Associated with urbanization, industrialization,
migration,
poverty, illiteracy, poor sanitation.
3)Serious impact on health & economic status of
people.
4)Costs billions of dollars across the world.
SOCIO ECONOMIC FACTORS
INCUBATION PERIOD
IP
INTRINSIC(MAN)
PRE PATENT CLINICAL
EXTRINSIC(MOSQ)
Inoculation of
infective larva to the
first appearance of
detectable Mf.
Inoculation of infective
larva to the
development of clinical
manifestations-8-
16mon. or longer.
Entry of Mf to
the
appearance
of inf.
Larvae-10-14
days.
NB.Mf does not multiply in the mosq.
• VECTORS
Wb - Culex quinquefaciatus(fatigans) in urban & semi-
urban areas.
- Anopheles in rural areas of Africa
- Aedes in Pacific islands
Bm - Mansonia annulifers & M.uniformis
COMMON BREEDING HABITS
1)CULEX-cess pools, soakage pits, ill maintained drains,
septic tanks, open ditches, burrow pits,etc.
2)MANSONIA-confined to areas where PISTIA plants are
there.
SEPTIC PITS & DRAINS CONTAINING
STAGNANT WATER.
PISTIA PLANTS
• MODE OF
TRANSMISSION
By the bite of infected
vector mosq.
Transmission depends
upon the man -
mosq.contact (eg.infective
biting rate).
NOTE - as many as 15,000
bites are necessary to
produce infection.
VECTOR CONTROL
VECTORS: C.tritaenorhynchus,C.gelidus C.vishnui.
Principles of arthropod control:
• Environmental control
• Chemical control
• Biological control
• Genetic control
• Newer methods
NB :”Integrated approach”
• Life history of MOSQUITO:
• Mosquito control measures:
1.Anti larval measures
2.Anti adult measures
3.Personal protection
ANTI LARVAL MEASURES
1.Environmental control :best approach as results
are more permanent.
a. Source reduction-elimination of cesspools,
ditches.
b. Intermittent irrigation
c. Filling and drainage operation
d. Provision of piped water supply
e. Proper disposal of refuse.
• 2.Chemical control:
Commonly used larvicides are
• a. Mineral oil –diesel oil, kerosene, mosquito larvicidal oil, etc.
MOA :oil spreads and forms thin film which cuts air supply to
larvae .appl rate - 40to90 L/hectare once a week.
• b. Paris Green -[copper acetoarsenite] Micro crystalline powder
insoluble in water.
MOA-stomach poison. good sample contains 50% arsenious
oxide. Appl-2% dust which is prepared by adding 2kg of Paris
green and 8kg of diluent such as slaked lime in a rotary mixer.
Its dusted by hand, rotary blowers. Dosage 1kg/hectare of water
surface.
c. Synthetic Insecticides - Organophosphorus compounds like
FENTHION, CHLORPYRIFOS, ABATE etc.
abate-very effective and least toxic.ccn.-1ppm.
Toxicant Dosage/ha]
Abate 56-112
Fenthion 22-112
Chloropyrifos 11-16
3.Biological control- Small fish like Gambusia, lebister which
feed on larvae can be use in burrow pits, cesspools etc.
• 1. Residual sprays -DDT is the insecticide of choice. Dosage 1-2g of
pure DDT / sq.m applied 1-3 times a year to walls and other surfaces.
Malathion, propoxur- applied where DDT resistance encountered.
Toxicant dosage[g/sqm] avg,durationof
effectiveness
DDT 1-2 6-12 months
Malathion 2 3 “
2. Space sprays- sprayed into the atmosphere in the form of fog or mist
using hand guns or power sprays a.
Pyrethrum extract- excellant spray from pyrethrum flowers. Active
principle-pyrethrin is a nerve poison dose -1oz/1000 cft.
b. Residual insecticides- Malathion ,Fenitrothion for ULV fogging.
ANTI-ADULT MEASURES-
• 3. Genetic control- sterile male technique,cytoplasmic
incompatability,chromosomal translocation
• Newer methods -insect growth regulators,chemosterilants etc.
PERSONAL PROTECTION
[i] Mosquito nets - size of the holes 0.0475”
no. of holes/sq inch 150
[ii] Screening of buildings –Cu or Bronze gauze with
16 meshes/inch
[iii] Mosquito repellants or culicifuges-used mainly
on skin. Ex. Deet all-purpose
repellant
“INTEGRATED APPROACH”
Anatomy
1–2 days
5–7 days
1–2 days
2–3 days
Eggs
Anopheles
Mansonia
Aedes
Culex
Culex larvae & pupa
Anopheles adult
Culex adult
Aedes adult
Mansonia adult
Integrated Approach
• Anti-larval:
• Environmental control: source reduction
• Chemical control: mineral oil, paris green, synthetic
• Biological control: Gamusia affinis, Lebister reticularis
• Anti-adult:
• Residual spray: DDT, Lindane, Malathion
• Space spray: Pyrethrum, Fenitrothion
• Genetic control: sterile male, cytoplasmic incompatibility,
chromosomal translocations
• Personal protective measures:
• Mosquito net: size of pore < 0.0475 inch
• Screening: windows
• Repellents: Diethyltoluamide (DEET), Indalone
Thanks

Mais conteúdo relacionado

Semelhante a JE & Filariasis.pptx

Epidemiology of malaria
Epidemiology of malariaEpidemiology of malaria
Epidemiology of malariaAnilKumar5746
 
Japanese Encephalitis
Japanese EncephalitisJapanese Encephalitis
Japanese EncephalitisKULDEEP VYAS
 
Japanese encephalitis_6th batch_NAIHS_Devlop Shrestha
Japanese encephalitis_6th batch_NAIHS_Devlop ShresthaJapanese encephalitis_6th batch_NAIHS_Devlop Shrestha
Japanese encephalitis_6th batch_NAIHS_Devlop ShresthaDevlop Shrestha
 
Yellow fever
Yellow feverYellow fever
Yellow fevertamil11
 
Vector borne diseases.pptx
Vector borne diseases.pptxVector borne diseases.pptx
Vector borne diseases.pptxdeepamanandhar1
 
Japanese encephalitis
Japanese encephalitisJapanese encephalitis
Japanese encephalitisSaleem sayed
 
Characteristic features of a vector organism
Characteristic features of a vector organismCharacteristic features of a vector organism
Characteristic features of a vector organismPuja Ray
 
Monkeypox by Dr O.O. Afuye
Monkeypox by Dr O.O. AfuyeMonkeypox by Dr O.O. Afuye
Monkeypox by Dr O.O. AfuyeOlubunmi Afuye
 
Japanese Encephalitis
Japanese EncephalitisJapanese Encephalitis
Japanese EncephalitisPallab Nath
 
japanese encephalitis
japanese encephalitisjapanese encephalitis
japanese encephalitisPallab Nath
 
MALARIA DAY - 25- APRIL- 2022.pptx
MALARIA DAY - 25- APRIL- 2022.pptxMALARIA DAY - 25- APRIL- 2022.pptx
MALARIA DAY - 25- APRIL- 2022.pptxAbhishekSamuel14
 
Japanese Encephalitis: Case in Odisha
Japanese Encephalitis: Case in Odisha Japanese Encephalitis: Case in Odisha
Japanese Encephalitis: Case in Odisha Subash Patra
 
Malaria pathogenesis, prevention and control
Malaria  pathogenesis, prevention and controlMalaria  pathogenesis, prevention and control
Malaria pathogenesis, prevention and controlEkehChukwuemekaObinn
 
Neglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxNeglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxAdhyaDubey1
 
Neglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxNeglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxAdhyaDubey1
 
HLTH 104 Chapter 05
HLTH 104 Chapter 05HLTH 104 Chapter 05
HLTH 104 Chapter 05misteraugie
 

Semelhante a JE & Filariasis.pptx (20)

Epidemiology of malaria
Epidemiology of malariaEpidemiology of malaria
Epidemiology of malaria
 
Japanese Encephalitis
Japanese EncephalitisJapanese Encephalitis
Japanese Encephalitis
 
Japanese encephalitis_6th batch_NAIHS_Devlop Shrestha
Japanese encephalitis_6th batch_NAIHS_Devlop ShresthaJapanese encephalitis_6th batch_NAIHS_Devlop Shrestha
Japanese encephalitis_6th batch_NAIHS_Devlop Shrestha
 
Yellow fever
Yellow feverYellow fever
Yellow fever
 
Vector borne diseases.pptx
Vector borne diseases.pptxVector borne diseases.pptx
Vector borne diseases.pptx
 
Japanese encephalitis
Japanese encephalitisJapanese encephalitis
Japanese encephalitis
 
Characteristic features of a vector organism
Characteristic features of a vector organismCharacteristic features of a vector organism
Characteristic features of a vector organism
 
Arbovirus An Overview
Arbovirus An OverviewArbovirus An Overview
Arbovirus An Overview
 
Monkeypox by Dr O.O. Afuye
Monkeypox by Dr O.O. AfuyeMonkeypox by Dr O.O. Afuye
Monkeypox by Dr O.O. Afuye
 
Japanese Encephalitis
Japanese EncephalitisJapanese Encephalitis
Japanese Encephalitis
 
japanese encephalitis
japanese encephalitisjapanese encephalitis
japanese encephalitis
 
MALARIA DAY - 25- APRIL- 2022.pptx
MALARIA DAY - 25- APRIL- 2022.pptxMALARIA DAY - 25- APRIL- 2022.pptx
MALARIA DAY - 25- APRIL- 2022.pptx
 
Japanese Encephalitis: Case in Odisha
Japanese Encephalitis: Case in Odisha Japanese Encephalitis: Case in Odisha
Japanese Encephalitis: Case in Odisha
 
Dengue ppt
Dengue pptDengue ppt
Dengue ppt
 
Plague
Plague Plague
Plague
 
Malaria pathogenesis, prevention and control
Malaria  pathogenesis, prevention and controlMalaria  pathogenesis, prevention and control
Malaria pathogenesis, prevention and control
 
Neglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxNeglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptx
 
Neglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxNeglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptx
 
malaria.pptx
malaria.pptxmalaria.pptx
malaria.pptx
 
HLTH 104 Chapter 05
HLTH 104 Chapter 05HLTH 104 Chapter 05
HLTH 104 Chapter 05
 

Mais de Rahul Netragaonkar (20)

HISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.pptHISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.ppt
 
commu-ppt.ppt
commu-ppt.pptcommu-ppt.ppt
commu-ppt.ppt
 
CHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.pptCHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.ppt
 
Foundation Of Communication.pptx
Foundation Of Communication.pptxFoundation Of Communication.pptx
Foundation Of Communication.pptx
 
Influenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptxInfluenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptx
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
 
cholera.ppt
cholera.pptcholera.ppt
cholera.ppt
 
Diabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptxDiabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptx
 
Descriptive Studies.pptx
Descriptive Studies.pptxDescriptive Studies.pptx
Descriptive Studies.pptx
 
Case control studies.ppt
Case control studies.pptCase control studies.ppt
Case control studies.ppt
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
 
Dengue Fever.ppt
Dengue Fever.pptDengue Fever.ppt
Dengue Fever.ppt
 
Cholera ppt.ppt
Cholera ppt.pptCholera ppt.ppt
Cholera ppt.ppt
 
C05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.pptC05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.ppt
 
cancer-ppt.pptx
cancer-ppt.pptxcancer-ppt.pptx
cancer-ppt.pptx
 
swine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptxswine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptx
 
Cancer.pptx
Cancer.pptxCancer.pptx
Cancer.pptx
 
Mumps & Rubella.pptx
Mumps & Rubella.pptxMumps & Rubella.pptx
Mumps & Rubella.pptx
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
ARI & Influenza.pptx
ARI & Influenza.pptxARI & Influenza.pptx
ARI & Influenza.pptx
 

Último

Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 

Último (20)

Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 

JE & Filariasis.pptx

  • 1. Japanese Encephalitis & Filariasis Dr. Rahul Netragaonkar Professor Dept. Of Community Medicine Zydus Medical College, Dahod
  • 2. INTRODUCTION  Mosquito Borne Encephalitis Caused By Group B Arbovirus (Flavi Virus) And Transmitted By Culicine Mosquitoes.  Zoonotic Disease (Metazoonoses)  Rural Disaease  Iceberg Disease  Exhibits Cyclical Trend
  • 3. History • 1871 Japanese Encephalitis Described In Japan. • 1934 Japanese Encephalitis Virus Was Isolated.
  • 4. World Scenario 50000 Cases Of Je Occur Globally Each Year With 11000 De Aths And Nearly 9000 Disabled. Sporadic Cases (Occasional Cases, Widely Distributed In Time And Place): Are Observed In China, Japan, Taiwan, Korea, Philippines, Indonesia, Malaysia, Singapore, Myanmar, Bangladesh And Eastern Areas Of Russia. Regional, Seasonal Outbreaks : Occurs In Thailand, Parts Of India And Sri Lanka.
  • 5.
  • 6. INDIAN SCENARIO • JE first isolated in 1955 at Vellore, Tamil Nadu. • Subsequently, the outbreaks have occurred in 25 States / Union Territories of India. • JE virus infection is widespread and is particularly very high in Southern States of India viz., Andhra Pradesh (AP) Tamil Nadu and some parts of Karnataka.
  • 7.
  • 8. NB: Indian authorities have reported 6171 cases nation-wide, including 5700 cases and 1315 deaths in Uttar Pradesh alone. YEAR CASES DEATHS 1998 1999 2000 2001 2002 2003 2004 2005 2120 3428 2593 2061 1765 2241 1695 6200 507 680 556 479 460 670 367 1315 INCIDENCE OF JE
  • 10. NATURAL CYCLE OF JE VIRUS
  • 11. Animal Reservoirs • Pigs Major Vertebrate Hosts Considered As ‘Amplifiers’ Of Virus • Cattles/Buffaloes Not Natural Hosts Of Je Virus Act As ’Mosquitc Attractants’ • Birds Pond Herons,cattle Ergets,poultry,ducks Nb:horses Are Only Animals Which Manifest Je Virus Infection.
  • 12.
  • 13. Host Factors  Age: Majority Of Cases Are Children Less Than 15 Years (85%) Or Over 60 Years (10%).  Sex: Males Are More Affected Than Females.  Population Mobility Migration Of People From Endemic Areas To receptive areas.  Occupation Mostly A Rural Disease , Closely Related To Agricultural Practises.
  • 14. ENVIRONMENTAL FACTORS  Season Je Is A Seasonal Disease Prevalence Is From May To October ( Related To Agricultural Practices).  Rainfall Increases The Opportunities For Breeding Of Mosquitoes.
  • 15. VECTOR OF JE Culicine Mosquitoes. (C.Tritaeniorhynchus,c.Vishnui, C.Gelidus) Some Anophelines. C.Tritaeniorhynchus Has Been Implicated As Important Vector In South India.
  • 16. HABITS Breeding Habits Breed In Rice Fields, Shallow Ditches And Pools. Choice Of Host Zoophilic,feeding Primarily On Animal Hosts. Time Of Biting Usually At Nights.
  • 17. MODES OF TRANSMISSION  Disease Is Transmitted To Man By Bite Of Infected Mosquitoes.  No Man To Man Transmission  Man Is Incidental “Dead End” Host. Incubation Period Varies From 5-15 Days
  • 19. PATHOGENESIS • Neurotransmitter receptors are involved in binding of JE virus to cells in CNS. • Sensitized T cells stimulate inflammatory Response by activating macrophages, lymphocytes Perivascular space and parenchyma to form glial nodules CD4 T cells - CFS, parenchyma B cells - perivascular space
  • 20. CLINICAL FEATURES • Divided into three stages: 1. Prodromal stage 2. Encephalitic stage 3. Late stage
  • 21. CLINICAL FEATURES • Incubation period-5 to 16 days • Disease:asymptomatic infection=1:250 to 1:1000 • Represents tip of iceberg • Disease depends on –severity of infection susceptibility of host location of agent • It is characterized by CNS involvement • Japanese encephalitis is also called BRAIN FEVER
  • 22. SYMPTOMS AND SIGNS • PRODROMAL PHASE:- High grade fever, headache malaise Duration :6 days • ENCEPHALITIC STAGE:- High fever, severe head ache, nuchal rigidity, focal CNS signs, seizures, altered sensorium, abnormal doll’s eye moments, absent corneal reflex, pupillary reflex, deviation of angle of mouth, loss of consciousness etc. • Symptoms and signs of raised ICT-headache, vomiting, hemiplegia,bradycardia,irregular breathing. • Signs and symptoms of meningeal irration-kernigs sign
  • 25. • LATE STAGE:- Begins when active inflammation is at end i.e.temp. and ESR touch normal Mental impairment Increased deep tendon reflexes Paresis of UMN lesion - LMN lesion type - Speech impairment • COMPLICATIONS:- Death 35 - 50% - short prodromal stage - deep coma - hypertonia - tachypnea NB:If patient survives, complications are as that of late stage. • JE is the disease in children with early mortality.
  • 26. DIAGNOSIS • Clinical signs and symptoms • LAB DIAGNOSIS:- CSF lymphocytic pleocytosis Normal glucose level • SEROLOGICAL TESTS:- Detection of IgM antibodies –first week • NEW SEROLOGICAL TEST:- ELISA shows sensitivity of 88% -with sera 81% -with CSF
  • 27. Principles of Control : • No specific treatment per se. • Vector control is the main mode of prevention of an individual and community as a whole. • Control of amplifier hosts. • Vaccination.
  • 28. Management of J E Only symptomatic treatment • Maintenance of airway • Fluid and electrolyte balance • Control of convulsions, raised Intra Cranial Pressure, temperature
  • 29. FILARIASIS • INTRODUCTION Worldwide prevalent, arthropod borne, causing permanent, long term disability & disfigurement & associated with social & economic stigma. It causes-Isolation -Psychological stress -Family discord -Impair employment -Impair mobility & domestic activities
  • 31. Lymphatic filariasis • Caused by W.Bancrofti B.Malayi B.Timori History: 600 BC-SUSHRUTA described ELEPHENTANOID LEG. 1709 ad-the term malabar leg was applied by clarke. 1866 ad-Wucherer demonstrated mf in chylous urine. 1876 ad-bancroft described female adult worm. 1878 ad-manson identified culex as the vector & Described periodicity. This was the first discovery of insect transmission of a Human disease.
  • 32. PROBLEM STATEMENT • Widely distributed in tropics & sub-tropics-ASIA, AFRICA, WESTERN PACIFIC, SOUTH AMERICA. • Most seriously affected areas are INDIA, SOUTH EAST ASIA, CHINA, EAST COAST of AFRICA & NEW GUINEA. • Affecting 120 million people in 83 countries. • 40% of the affected people are in INDIA, 33% in AFRICA.
  • 33. LOA LOA (LOAIASIS) • Confined to Africa. • Vector Chrysops flies. They live in the rainy forest. • Monkeys are the reservoir hosts. ONCHOCERCA VOLVULUS (RIVER BLINDNESS)  Distributed in Africa & South America.  Endemic in West Africa, Equatorial & East Africa & Sudan.  Vector - black fly = Simulum damnosum.
  • 34. • W.bancrofti widely distributed throughout the tropics & sub tropics which account for nearly 90% of the lymphatic filariasis. • Brugia malayi has only been recognized in ASIA & localized to INDONESIA, MALAYSIA, PHILIPPINES, THAILAND, VIETNAM, CHINA, SOUTH KOREA, INDIA. • Brugia timori is prevalent in islands of TIMOR & FLORES. First described in 1964 from the island of TIMOR of INDONESIA. LYMPHATIC FILARIASIS
  • 35.
  • 36. • IN INDIA Only W.bancrofti & B.malayi are seen. Endemic along coastal states – increasing every year. Heavily infected areas are found in U.P, Bihar, Jharkhand, A.P., Orissa, T.N., Kerala & Gujarat. B.malayi – KERALA - largest endemic area. ASSAM, ORISSA, M.P., W.B -epidemic pockets.
  • 37.
  • 38. • SYMPTOM PREVALENCE - 27 million - GENITALFILARIASIS 16 million - ELEPHANTIASIS of LEG
  • 39. EPIDEMIOLOGY AGENTS W.BANCROFTI B.MALAYI B.TIMORI Definite host is MAN. Intermediate host is MOSQUITO. Adult worms live in LYMPHATIC SYSTEM remain coiled together. Male 2.5-4cm. & Female 8-10cm. Mf are seen in blood, lung (capillaries), kidney (glomerular tufts).
  • 40.
  • 41. HUMANS - is a person with circulating Mf in peripheral blood. ANIMALS - no animal reservoir for Wb & Bt.Bm - dogs, cats, monkeys, wild carnivores & rodents. Reservoir
  • 42.
  • 43. MAN is a natural host. Age: all ages are susceptible. infectious rate rises with age up to 20-30yrs. Sex :higher in men. Migration: causes extension of filariasis into areas previously non endemic. Immunity: resistance to infection after many years of exposure. HOST FACTORS
  • 44. • A) Climate: is an imp. Factor in the epidemiology of filariasis.it influences 1)Mosquito-longevity & breeding 2)determines the development of parasite in the vector Max. prevalence observed at temp.22-38°C humidity-70% B) Town planning: rapid urbanization in INDIA causing inadequate sewage disposal – aggravating the problem. C) Drainage: mosq. breed profusely in polluted water. ENVIRONMENTAL FACTORS
  • 45. 1)Major leading cause of disability in the world. 2)Associated with urbanization, industrialization, migration, poverty, illiteracy, poor sanitation. 3)Serious impact on health & economic status of people. 4)Costs billions of dollars across the world. SOCIO ECONOMIC FACTORS
  • 46. INCUBATION PERIOD IP INTRINSIC(MAN) PRE PATENT CLINICAL EXTRINSIC(MOSQ) Inoculation of infective larva to the first appearance of detectable Mf. Inoculation of infective larva to the development of clinical manifestations-8- 16mon. or longer. Entry of Mf to the appearance of inf. Larvae-10-14 days. NB.Mf does not multiply in the mosq.
  • 47. • VECTORS Wb - Culex quinquefaciatus(fatigans) in urban & semi- urban areas. - Anopheles in rural areas of Africa - Aedes in Pacific islands Bm - Mansonia annulifers & M.uniformis COMMON BREEDING HABITS 1)CULEX-cess pools, soakage pits, ill maintained drains, septic tanks, open ditches, burrow pits,etc. 2)MANSONIA-confined to areas where PISTIA plants are there.
  • 48. SEPTIC PITS & DRAINS CONTAINING STAGNANT WATER.
  • 50. • MODE OF TRANSMISSION By the bite of infected vector mosq. Transmission depends upon the man - mosq.contact (eg.infective biting rate). NOTE - as many as 15,000 bites are necessary to produce infection.
  • 51. VECTOR CONTROL VECTORS: C.tritaenorhynchus,C.gelidus C.vishnui. Principles of arthropod control: • Environmental control • Chemical control • Biological control • Genetic control • Newer methods NB :”Integrated approach”
  • 52. • Life history of MOSQUITO:
  • 53. • Mosquito control measures: 1.Anti larval measures 2.Anti adult measures 3.Personal protection ANTI LARVAL MEASURES 1.Environmental control :best approach as results are more permanent. a. Source reduction-elimination of cesspools, ditches. b. Intermittent irrigation c. Filling and drainage operation d. Provision of piped water supply e. Proper disposal of refuse.
  • 54. • 2.Chemical control: Commonly used larvicides are • a. Mineral oil –diesel oil, kerosene, mosquito larvicidal oil, etc. MOA :oil spreads and forms thin film which cuts air supply to larvae .appl rate - 40to90 L/hectare once a week. • b. Paris Green -[copper acetoarsenite] Micro crystalline powder insoluble in water. MOA-stomach poison. good sample contains 50% arsenious oxide. Appl-2% dust which is prepared by adding 2kg of Paris green and 8kg of diluent such as slaked lime in a rotary mixer. Its dusted by hand, rotary blowers. Dosage 1kg/hectare of water surface.
  • 55. c. Synthetic Insecticides - Organophosphorus compounds like FENTHION, CHLORPYRIFOS, ABATE etc. abate-very effective and least toxic.ccn.-1ppm. Toxicant Dosage/ha] Abate 56-112 Fenthion 22-112 Chloropyrifos 11-16 3.Biological control- Small fish like Gambusia, lebister which feed on larvae can be use in burrow pits, cesspools etc.
  • 56. • 1. Residual sprays -DDT is the insecticide of choice. Dosage 1-2g of pure DDT / sq.m applied 1-3 times a year to walls and other surfaces. Malathion, propoxur- applied where DDT resistance encountered. Toxicant dosage[g/sqm] avg,durationof effectiveness DDT 1-2 6-12 months Malathion 2 3 “ 2. Space sprays- sprayed into the atmosphere in the form of fog or mist using hand guns or power sprays a. Pyrethrum extract- excellant spray from pyrethrum flowers. Active principle-pyrethrin is a nerve poison dose -1oz/1000 cft. b. Residual insecticides- Malathion ,Fenitrothion for ULV fogging. ANTI-ADULT MEASURES-
  • 57. • 3. Genetic control- sterile male technique,cytoplasmic incompatability,chromosomal translocation • Newer methods -insect growth regulators,chemosterilants etc. PERSONAL PROTECTION [i] Mosquito nets - size of the holes 0.0475” no. of holes/sq inch 150 [ii] Screening of buildings –Cu or Bronze gauze with 16 meshes/inch [iii] Mosquito repellants or culicifuges-used mainly on skin. Ex. Deet all-purpose repellant “INTEGRATED APPROACH”
  • 59. 1–2 days 5–7 days 1–2 days 2–3 days
  • 66. Integrated Approach • Anti-larval: • Environmental control: source reduction • Chemical control: mineral oil, paris green, synthetic • Biological control: Gamusia affinis, Lebister reticularis • Anti-adult: • Residual spray: DDT, Lindane, Malathion • Space spray: Pyrethrum, Fenitrothion • Genetic control: sterile male, cytoplasmic incompatibility, chromosomal translocations • Personal protective measures: • Mosquito net: size of pore < 0.0475 inch • Screening: windows • Repellents: Diethyltoluamide (DEET), Indalone